NDC codes

464160 NDC codes with hospital pricing data in the network.

• NDC 00067-5500-50 — oxymetazoline 0.05% Nasal Sp 15 mL (15 hospitals, 1,161–1,269 samples)
• NDC 09991322000 — ALTEPLASE INTRAOCULAR INJ 12.5 MCG/0.1 ML (TV=0.5 ML) (23 hospitals, 648–1,269 samples)
• NDC 09991294800 — ALTEPLASE 1 MG/ML INFUSION (PED CATHETER) (22 hospitals, 648–1,269 samples)
• NDC 00048-1100-03 — levothyroxine 175 mcg Tab (6 hospitals, 1,187–1,268 samples)
• NDC 55150-0248-47 — INJECTION, LEVETIRACETAM, 10 MG (48 hospitals, 1,097–1,268 samples)
• NDC 00074-7126-11 — Divalproex Tab ER 500 mg (48 hospitals, 1,195–1,267 samples)
• NDC 09990300700 — HEPARIN (PORCINE) 25,000 UNIT/250 ML (100 UNIT/ML) IN DEXTROSE 5 % IV (21 hospitals, 169–1,267 samples)
• NDC 63323004444 — CYANOCOBALAMIN 1000 MCG/ML IJ SOLN (128 hospitals, 906–1,266 samples)
• NDC 00071-0156-23 — atorvastatin 20 mg Tab (25 hospitals, 1,194–1,266 samples)
• NDC 25021-0308-84 — Esmolol 2,500 mg in 250 mL PREMIX (102 hospitals, 1,121–1,265 samples)
• NDC 9004727 — Methylprednisolone Sod Succ For Inj PF 125 MG (Base Equiv) (44 hospitals, 572–1,265 samples)
• NDC 00409330024 — CIPROFLOXACIN IN D5W 400 MG/200ML IV SOLN (208 hospitals, 148–1,264 samples)
• NDC 36000000824 — ciprofloxacin 200 mg/100 mL in 5 % dextrose intravenous piggyback (161 hospitals, 148–1,264 samples)
• NDC 0409206610 — LIDOCAINE (PF) 20 MG/ML (2 %) INJ SOLN (27 hospitals, 310–1,264 samples)
• NDC 0409427916 — LIDOCAINE 10 MG/ML (1 %) INJECTION (SO) (46 hospitals, 310–1,264 samples)
• NDC 0409471325 — LIDOCAINE PF 1 % EPIDURAL INFUSION (ANESTHESIA ONLY) (21 hospitals, 310–1,264 samples)
• NDC 5515015974 — LIDOCAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION (29 hospitals, 310–1,264 samples)
• NDC 6332320801 — LIDOCAINE (PF) 20 MG/ML (2 %) INTRAVENOUS SOLUTION (42 hospitals, 310–1,264 samples)
• NDC 6332349227 — LIDOCAINE 10 MG/ML (1 %) INFUSION (ANESTHESIA ONLY) (SO) (55 hospitals, 310–1,264 samples)
• NDC 6332349526 — LIDOCAINE (PF) 20 MG/ML (2 %) INJECTION SOLUTION (SO) (22 hospitals, 310–1,264 samples)
• NDC 6332349527 — LIDOCAINE (PF) 20 MG/ML (2 %) INJECTION SOLUTION (SO) (51 hospitals, 310–1,264 samples)
• NDC 00641611610 — AMPICILLIN-SULBACTAM 1.5 GRAM SOLUTION FOR INJECTION (125 hospitals, 256–1,264 samples)
• NDC 72485041610 — AMPICILLIN-SULBACTAM 1.5 GRAM SOLUTION FOR INJECTION (65 hospitals, 256–1,264 samples)
• NDC 00407294302 — GADOTERATE MEGLUMINE 7.5 MMOL/15ML SOLUTION (48 hospitals, 598–1,264 samples)
• NDC 74725-0100-25 — GALLIUM GA 68 GOZETOTIDE (ILLUCCIX) 25 MCG IV KIT (55 hospitals, 1,021–1,264 samples)
• NDC 63323001020 — GENTAMICIN SULFATE 40 MG/ML IJ SOLN (477 hospitals, 156–1,263 samples)
• NDC 70069-0231-01 — BRIMONIDINE 0.2 % OPHT DROP (203 hospitals, 1,046–1,262 samples)
• NDC 43598-0529-36 — Neostigmine Inj 1 mg/mL (IV) (58 hospitals, 1,019–1,262 samples)
• NDC 00409733221 — cefTRIAXone 1 gram solution for injection (129 hospitals, 470–1,262 samples)
• NDC 00054-0668-82 — alvimopan 12 mg Cap (41 hospitals, 1,199–1,262 samples)
• NDC 00121-0910-40 — Bismuth Subsal Oral Susp 525 mg/30 mL UD (33 hospitals, 1,172–1,262 samples)
• NDC 99999-1234-17 — METRONIDAZOLE 5 MG/ML IV SYRINGE (PEDS)(FROM PREMIX) (4 hospitals, 1,262 samples)
• NDC 00143-9891-25 — INJECTION, ONDANSETRON HYDROCHLORIDE, PER 1 MG (2 hospitals, 1,262 samples)
• NDC 76075-0101-01 — CARFILZOMIB 60 MG IV SOLR (325 hospitals, 1,045–1,261 samples)
• NDC 45802027603 — HYDROCORTISONE 1 % EX OINT (343 hospitals, 1,134–1,260 samples)
• NDC 00093-3145-01 — cephalexin 250 mg Cap (128 hospitals, 1,143–1,260 samples)
• NDC 68094-0494-61 — IBUPROFEN 100 MG/5 ML ORAL SUSPENSION (70 hospitals, 1,251–1,260 samples)
• NDC 00781-7296-85 — ALBUTEROL SULFATE HFA 90 MCG/ACTUATION AEROSOL INHALER (102 hospitals, 702–1,260 samples)
• NDC 00338070948 — POTASSIUM CHLORIDE 10 MEQ/100ML IV SOLN (331 hospitals, 189–1,260 samples)
• NDC 43598-0426-60 — INJECTION, BORTEZOMIB, 0.1 MG (93 hospitals, 1,116–1,260 samples)
• NDC 55150-0337-01 — Bortezomib Inj 2.5 mg/mL (VIAL)(SubQ) (100 hospitals, 1,116–1,260 samples)
• NDC 43598058001 — BUPRENORPHINE 4 MG-NALOXONE 1 MG SUBLINGUAL FILM (87 hospitals, 126–1,260 samples)
• NDC 68001-0525-32 — FLUOROURACIL INJECTION (21 hospitals, 1,260 samples)
• NDC 64679075910 — FUROSEMIDE 10 MG/ML INJECTION SOLUTION (39 hospitals, 441–1,260 samples)
• NDC 64679075912 — FUROSEMIDE 10 MG/ML INJECTION SOLUTION (29 hospitals, 441–1,260 samples)
• NDC 00409963114 — FUROSEMIDE 10 MG/ML INJECTION SYRINGE (25 hospitals, 441–1,260 samples)
• NDC 121177505 — Codeine-guaiFENesin 10-100 mg/5 mL Liqd 5 mL CUP (126 hospitals, 1,097–1,259 samples)
• NDC 43598-0914-11 — Vasopressin Inj 20 units/1 mL (UD) (65 hospitals, 917–1,259 samples)
• NDC 436067216 — sodium hypochlorite (1/4 strength) 0.125 % Soln 473 mL BOTTLE (149 hospitals, 1,097–1,259 samples)
• NDC 60505082901 — FLUTICASONE PROPIONATE NASAL SUSP 50 MCG/ACT (429 hospitals, 1,115–1,259 samples)